Literature DB >> 17320821

Augmentation of vascular permeability of VEGF is enhanced by KDR-binding proteins.

Yasuo Yamazaki1, Yuta Nakano, Takahisa Imamura, Takashi Morita.   

Abstract

VEGF165 is a key regulator of angiogenesis and a potent vascular permeability factor. Using snake venom proteins as tools, we demonstrate the enhanced vascular leakage of VEGF by KDR-binding proteins. The snake venom-derived KDR-specific VEGF, vammin, potently enhanced vascular leakage compared with other known permeability-enhancing factors including VEGF165, while KDR-bp from snake venom, a KDR antagonist of endothelial cell growth was a very weak permeability enhancer. Unexpectedly when co-administrated, KDR-bp synergistically enhanced either vammin or VEGF165-stimulated vascular leakage, despite its antagonistic effect on cell growth. This augmenting effect was specifically observed in the combined administration of KDR-bp with either VEGF165 or vammin, but not other combination of known permeability-enhancing factors. We further demonstrated a similar increased vascular leakage by the combined administration of VEGF165 and TIMP-3, the only known endogenous antagonist of KDR. Our findings implicate TIMP-3 as a critical player in the vascular leakage-enhancing effect of VEGF165 in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17320821     DOI: 10.1016/j.bbrc.2007.02.038

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model.

Authors:  Florence T H Wu; Marianne O Stefanini; Feilim Mac Gabhann; Christopher D Kontos; Brian H Annex; Aleksander S Popel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-09       Impact factor: 4.733

Review 2.  Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use?

Authors:  Alejandro R Chade; Nicholas Stewart
Journal:  J Am Soc Hypertens       Date:  2013-02-19

3.  Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability.

Authors:  Irina N Gavrilovskaya; Elena E Gorbunova; Natalie A Mackow; Erich R Mackow
Journal:  J Virol       Date:  2008-03-26       Impact factor: 5.103

4.  Snake venom Vascular Endothelial Growth Factors (VEGF-Fs) exclusively vary their structures and functions among species.

Authors:  Yasuo Yamazaki; Yukiko Matsunaga; Yuko Tokunaga; Shinya Obayashi; Mai Saito; Takashi Morita
Journal:  J Biol Chem       Date:  2009-02-10       Impact factor: 5.157

5.  HIV-1 Tat mimetic of VEGF correlates with increased microvessels density in AIDS-related diffuse large B-cell and Burkitt lymphomas.

Authors:  J Nyagol; G De Falco; S Lazzi; A Luzzi; G Cerino; S Shaheen; N Palummo; C Bellan; D Spina; L Leoncini
Journal:  J Hematop       Date:  2008-04-16       Impact factor: 0.196

6.  Comparative compositional and functional venomic profiles among venom specimens from juvenile, subadult and adult Russell's viper ( Daboia siamensis ): correlation with renal pathophysiology in experimental rabbits.

Authors:  Narongsak Chaiyabutr; Lawan Chanhome; Taksa Vasaruchapong; Panithi Laoungbua; Orawan Khow; Anudep Rungsipipat; Onrapak Reamtong; Visith Sitprija
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2022-04-04

7.  In vivo tumor targeting and imaging with anti-vascular endothelial growth factor antibody-conjugated dextran-coated iron oxide nanoparticles.

Authors:  Wan-Ju Hsieh; Chan-Jung Liang; Jen-Jie Chieh; Shu-Huei Wang; I-Rue Lai; Jyh-Horng Chen; Fu-Hsiung Chang; Wei-Kung Tseng; Shieh-Yueh Yang; Chau-Chung Wu; Yuh-Lien Chen
Journal:  Int J Nanomedicine       Date:  2012-06-07

8.  Quantitative high-throughput profiling of snake venom gland transcriptomes and proteomes (Ovophis okinavensis and Protobothrops flavoviridis).

Authors:  Steven D Aird; Yutaka Watanabe; Alejandro Villar-Briones; Michael C Roy; Kouki Terada; Alexander S Mikheyev
Journal:  BMC Genomics       Date:  2013-11-14       Impact factor: 3.969

9.  Translational Venomics: Third-Generation Antivenomics of Anti-Siamese Russell's Viper, Daboia siamensis, Antivenom Manufactured in Taiwan CDC's Vaccine Center.

Authors:  Libia Sanz; Sarai Quesada-Bernat; Pei Yu Chen; Cheng Dow Lee; Jen Ron Chiang; Juan J Calvete
Journal:  Trop Med Infect Dis       Date:  2018-06-15

10.  Systemic vascular leakage induced in mice by Russell's viper venom from Pakistan.

Authors:  Alexandra Rucavado; Teresa Escalante; Erika Camacho; José María Gutiérrez; Jay W Fox
Journal:  Sci Rep       Date:  2018-10-31       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.